Immune Mechanisms Underlying Neonatal Protection Following Maternal RSV Vaccination
International Journal of Molecular Sciences · 17.07.2026 · 27 (14) · 6363
DOI: 10.3390/ijms27146363 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 17.07.2026. Verfasst von Aikaterini I Nikolaou und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, School of Medicine, University of Ioannina, 45500 Ioannina, Greece. Hauptthemen laut MEDLINE: Immunity, Maternally-Acquired, Respiratory Syncytial Virus Infections, Respiratory Syncytial Virus Vaccines. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Respiratory syncytial virus (RSV) remains a major cause of severe lower respiratory tract infection in early infancy, a period characterized by immunological immaturity and limited capacity for effective antiviral responses. Maternal RSV vaccination has emerged as a successful strategy to protect newborns by inducing high concentrations of IgG1-dominant, prefusion F-specific antibodies, which are selectively and actively transported across the placenta. This review synthesizes current mechanistic insights into how maternally derived antibodies confer neonatal protection, focusing on (i) FcRn-mediated transplacental transport, (ii) IgG subclass-specific differences in transfer and half-life, and (iii) the role of Fc glycosylation in modulating Fcγ receptor engagement and effector functions. Beyond neutralization, vaccine-induced antibodies mediate Fc-dependent mechanisms such as antibody-dependent cellular cytotoxicity and phagocytosis, which may be preferentially enriched in the neonatal circulation. Although emerging systems serology data suggest qualitative selectivity in placental transfer, evidence remains heterogeneous and highlights the need for further clarification of glycosylation-dependent and glycosylation-independent pathways. The timing of vaccination, maternal antibody characteristics, and placental integrity critically influence neonatal antibody levels and the duration of passive immunity. Understanding these molecular determinants is essential for optimizing maternal RSV immunization strategies and improving early-life protection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, School of Medicine, University of Ioannina, 45500 Ioannina, Greece.
- Neonatal Intensive Care Unit, School of Medicine, University of Ioannina, 45500 Ioannina, Greece.
- School of Medicine, Faculty of Health Sciences, National and Kapodistrian University of Athens, 11527 Athens, Greece.
ORCID-Profile: Aikaterini I Nikolaou, Vasileios Giapros, Fani Ladomenou
Zitieren
APA
Nikolaou, A. I., Giapros, V., Kefala, M. A., Papanikolaou, N. G., Baltogianni, M., & Ladomenou, F. (2026). Immune Mechanisms Underlying Neonatal Protection Following Maternal RSV Vaccination. International Journal of Molecular Sciences, 27(14), 6363. https://doi.org/10.3390/ijms27146363
Vancouver
Nikolaou AI, Giapros V, Kefala MA, Papanikolaou NG, Baltogianni M, Ladomenou F. Immune Mechanisms Underlying Neonatal Protection Following Maternal RSV Vaccination. International Journal of Molecular Sciences. 2026;27(14):6363. doi:10.3390/ijms27146363
BibTeX
@article{Nikolaou2026,
author = {Nikolaou, Aikaterini I and Giapros, Vasileios and Kefala, Maria Alexandra and Papanikolaou, Nikolaos G and Baltogianni, Maria and Ladomenou, Fani},
title = {Immune Mechanisms Underlying Neonatal Protection Following Maternal RSV Vaccination},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {14},
pages = {6363},
doi = {10.3390/ijms27146363}
}
EUVIMED